![](/img/cover-not-exists.png)
ACTR-53. INTERIM ANALYSIS OF PHASE 1B/2 COMBINATION STUDY OF THE IDO PATHWAY INHIBITOR INDOXIMOD WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH TEMOZOLOMIDE-REFRACTORY PRIMARY MALIGNANT BRAIN TUMORS
Zakharia, Yousef, Munn, David, Link, Charles, Vahanian, Nicholas, Kennedy, EugeneVolume:
18
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now212.051
Date:
November, 2016
File:
PDF, 89 KB
english, 2016